Sep 28 close
Core Scientific shares fell 4.7% this week to $16.52, with commentary flagging the stock as overvalued against a GF Score of 29/100 and citing weak profitability and growth metrics. Separately, the company named Jay Elms as Chief Commercial Officer, a hire tied to its push into AI-focused computing infrastructure and its shift of capacity from Bitcoin mining toward hyperscale workloads. Coverage also raised permitting risk tied to a Texas data center freeze, alongside notes on CORZ's ERCOT-approved power position and customer concentration with CoreWeave, while peer Applied Digital and TeraWulf also traded lower on the day.
The stock sits below both its 50-day average of $19.17 and 200-day average of $19.80, with the 50-day below the 200-day, reflecting a broader downtrend; shares are down 36.3% over three months and 6.2% over one month, though still up 9.6% over six months. The GekkoIndex reads 63.3, placing CORZ in the Accumulation zone. Price stands 32.6% below Gekko Fair Value of $24.52.
Earnings are set for 23 October, 24 days out and inside a typical 20-day holding window, with the prior report showing a 12.6% reaction and an average absolute move of 9.5%. Over the last 90 days there have been 3 open-market insider purchases totaling $342,332, alongside 2 billionaire and 2 trailblazer holders. Unusual options activity over the last 30 days shows 3 signals, with call premium of $4.1 million versus put premium of $5,356. Analyst consensus stands at 12 buy, 1 hold ratings with a $33.90 target.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Core Scientific scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
Below 50 and 200-day
Close $16.52 is below the 50-day ($19.17) and 200-day ($19.80) averages, and the 50-day is below the 200-day.
See the chart63.3, Accumulation
Reading 63.3 is in the Accumulation zone.
See the GekkoIndex32.6% below
Price is 32.6% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 3 open-market insider purchases. Last 30 days: 3 unusual options signals.
See smart moneyReports in 24 days
Reports on Oct 23, 2026, 24 days away — inside a typical 20-trading-day hold.
See earningsNo data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Core Scientific closed at $16.52 on Sep 28, 2026, −1.9% over the past year, inside a 52-week range of $13.36 to $30.46.
Use the left and right arrow keys to read daily values.
Put CORZ on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Core Scientific operates computer facilities that generate digital currencies on its own behalf and also process blockchain transactions in return for digital asset rewards. It relies on specialized mining hardware housed in data centers it owns, and it has built a name around pairing this direct mining work with space it rents out to other large digital asset miners. Beyond running machines, the company designs blockchain platforms and software meant to help with managing infrastructure, strengthening security, improving mining efficiency, and keeping accurate records.
Its business is split into two segments, one built around selling equipment and the other around hosting. Through the hosting arm, outside mining companies can place their own machines in Core Scientific's facilities rather than operating independent sites.
Core Scientific is based in Austin, Texas, and its stock is listed on the NASDAQ under the ticker CORZ.
Core Scientific’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 63.3, in the Accumulation zone, up 5.2 points over five sessions.
Up 5.2 points over five sessions, from the Neutral zone.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 28 | +3.8% | −0.2% | ||
| Accumulation (current zone) | 190 | +2.3% | +2.3% | ||
| Neutral | 360 | +1.9% | +10.6% | ||
| Distribution | 85 | +1.3% | +12.5% | ||
| Selling | 3 | Too few readings yet | |||
Average CORZ share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Core Scientific trades 32.6% below Gekko Fair Value of $24.52, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Core Scientific shares are worth, recalculated every trading day.
$24.52
Gekko Fair Value, Sep 29, 2026
32.6% Undervalued
Insiders filed 3 open-market purchases in Core Scientific worth $342K, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$342Kin 3 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 17 | Weiss Eric Stanton director | Purchase | $98K |
| Aug 24 | CRAIN ELIZABETH director | Purchase | $110K |
| Aug 20 | Weiss Eric Stanton director | Purchase | $134K |
From Form 4 filings, dated to when each was filed.
No trades in CORZ were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Core Scientific has been buying back its own shares.
From company filings.
3signals, 100% of the flagged premium in calls.
Latest: Bullish flow on Sep 19, $636K in unusual premium.
4of the funds Gekko tracks hold CORZ.
Core Scientific reports on Oct 23, 2026, after the close (24 days away), and beat the EPS estimate in 1 of its last 8 reports.
Oct 23, 2026
Expected after the close, 24 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 28, 2026 | −$3.32 est −$0.06 | $164.2M est $141.1M | −12.6% |
| May 6, 2026 | −$0.11 est −$0.05 | $115.2M est $117.0M | +0.8% |
| Mar 2, 2026 | −$0.18 est −$0.12 | $79.76M est $119.0M | −9.8% |
| Oct 24, 2025 | −$0.46 est −$0.07 | $81.10M est $112.0M | +10.0% |
| Aug 8, 2025 | −$0.04 est −$0.07 | $78.63M est $111.3M | +1.3% |
| May 7, 2025 | −$0.13 est $0.02 | $79.53M est $85.18M | +5.1% |
| Feb 26, 2025 | −$0.13 est $0.05 | $94.93M est $97.06M | +9.7% |
| Nov 6, 2024 | −$1.17 est −$0.09 | $95.35M est $99.16M | +26.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Core Scientific is $33.90, +105.2% from the last close, from 13 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 13 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 25 | Clear Street | $30 | +81.6% |
| Sep 23 | UBS | $24 | +45.3% |
| Sep 21 | Rothschild & Co Redburn | $16 | −3.1% |
| Sep 17 | Wells Fargo | $28 | +69.5% |
| Aug 31 | Bernstein | $32 | +93.7% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Core Scientific’s market cap is $5.31B and revenue of $440.3M over the last twelve months.
Coverage of Core Scientific this week reads negative: 4 positive, 1 neutral and 6 negative headlines.
Core Scientific’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PAYXPaychex | Buying | 24.5% below |
| VRSKVerisk Analytics | Accumulation | 27.1% below |
| JJacobs Solutions | Accumulation | 6.2% above |
| AKAMAkamai Technologies | Neutral | 15.4% below |
| IRENIREN | Neutral | 24.3% below |
| TYLTyler Technologies | Accumulation | 15.0% below |
A peer links to its own page where one exists.
Core Scientific’s market cap is $5.31B at the Sep 28, 2026 close of $16.52, with 321.3M shares outstanding.
The consensus analyst 12-month price target for Core Scientific is $33.90, +105.2% from the last close. Of the 13 firms that rated the stock in the last 90 days, 12 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Core Scientific is undervalued: the Sep 28, 2026 close of $16.52 is 32.6% below Gekko Fair Value of $24.52. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Core Scientific is expected to report on Oct 23, 2026, after the market closes (24 days away). Analysts expect earnings of −$0.01 per share on revenue of $197.0M. Core Scientific beat the earnings estimate in 1 of its last 8 reports, moving 9.5% on average across the report.
Core Scientific’s 52-week high is $30.46 and its 52-week low is $13.36; it closed at $16.52 on Sep 28, 2026, −1.9% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and smart money) and 2 as headwinds (trend and earnings risk). The checklist is a description of current data, not a recommendation.
Gekko flagged 3 unusual options signals in Core Scientific over the last 30 days, with $4.06M of flagged premium in calls and $5K in puts. The latest, bullish flow, was on Sep 19, 2026 with $636K in unusual premium. The signal-by-signal table is in Gekko.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.